Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-14-029628
Filing Date
2014-06-11
Accepted
2014-06-11 10:54:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 138270
  Complete submission text file 0000000000-14-029628.txt   191592
Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827 908-574-4770
Bellerophon Therapeutics, Inc. (Filed for) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations